We empower your enzymes

INOFEA AG developed a patented platform technology capable to fit enzymes to industrial applications.
About enzzen® technology
Our enzymes have positively demonstrated substantial benefits to customers in
Our enzzen®-enzymes are
Our enzzen®-enzymes

Enzzen® technology platform

INOFEA developed a unique and patented technology platform called enzzen® to fit enzymes to industrial applications.

Empower your own enzymes

INOFEA works closely with its clients to provide them with a complex line of services that sustain their processes and products.

Direct sales of enzymes

INOFEA formulated several protein digestion enzymes for improved resistance to chaotropic conditions.

Enzzen® technology licensing

INOFEA`s enzzen® is embedded into a number of applications, focusing on streamlining our client’s processes.

Meet us


  • The 3rd Industrial Biocatalysis Symposium on June 10th, 2021, Wädenswil, Switzerland
Press Releases

INOFEA welcomes Dr. Carolina Giunta as Project Leader


Carolina joined the team of INOFEA in February 2021 as Project Leader. She graduated with a Ph.D. in chemistry in the field of enzyme bioconjugation at the University of Basel. Carolina has a deep experience in the application of the enzzen®-technology for empowering enzymes.

INOFEA successfully closed its Series B financing round


Muttenz, Switzerland, Nov. 16, 2020: End of September 2020 INOFEA AG executed the successful closure of its recent financing round Series B. “It was amazing to see that we have been able to oversubscribe our target, both with the support of existing and also of new shareholders”, said the CEO, Dr. Anne Timm. “The entire INOFEA Team and our Board are proud of this important milestone and we thank our investors who made this happen.” INOFEA will use its investment to grow its market position, mainly in the Pharma and Food segment. The constant growth of the customer base demonstrates the value of the technology in the white biotech sector. INOFEA’s clients are particularly in favour of the technology as it supports raw material, energy and cost savings when used in continuous manufacturing processes. The unique technology makes enzymes up to 20-35 times more stable and reusable. This supports a valuable contribution to the sustainability targets of the industry. INOFEA is in the process to file new patents, has a supply agreement, multiple research agreements and a license agreement in place. Beside Biocatalysis the company focuses on the market of diagnostics (biomarkers) where the enzzen®-enzyme technology makes complicated and for the patient painful biopsies obsolete. INOFEA is expanding its team, both on the technical and commercial side and an industry-seasoned dedicated Business Development Manager has been hired. This will enable the ambitious growth aspirations of the company in the coming years. INOFEA invites companies in the industry who are actively looking for enzymatic solutions for Biocatalysis and Diagnostics to enter into partnerships for the development of robust and recyclable enzymes.

INOFEA is certified to be one of the finalists of the EIT-Food Accelerator Network 2020


INOFEA is certified to be one of the finalists of EIT-Food Accelerator Network 2020, operated by MassChallenge Switzerland.
Read More
Go to Top